期刊文献+

胃肠道间质瘤26例临床分析

下载PDF
导出
摘要 目的探讨胃肠道间质瘤(GIST)的临床特点及诊治。方法对26例GIST的临床资料进行回顾性分析。结果26例GIST,男性18例,女性8例,年龄(46.8±10.3)岁。发生部位以胃(12例,46.2%)和空肠(7例,26.9%)为主。首发症状以腹痛、腹胀(18例,69.2%)和消化道出血(11例,42.3%)为主。均行外科手术切除。病理报告:良性16例,恶性10例。免疫组织化学:CD117阳性19例(73.1%),CD34阳性17例(65.4%)。良、恶性间质瘤瘤体直径比较差别有统计学意义(P<0.05)。结论(1)GIST消化道症状无特异性,术前确诊率低。(2)CD117和CD34阳性可以作为GIST的诊断标志,而肿瘤的大小是判断良恶性的重要指标。(3)手术切除是最有效的治疗手段。
出处 《福建医科大学学报》 2006年第1期74-75,共2页 Journal of Fujian Medical University
  • 相关文献

参考文献10

  • 1Mazur MT,Clark HB.Gastric stromal tumors:Reappraisal of histogenesis[J].Am J Surg Pathol.1983,7(16):507-519.
  • 2纪小龙,虞积耀.胃肠道间质瘤[J].诊断病理学杂志,2000,7(1):3-5. 被引量:155
  • 3Hirota S,Isozaki K,Moriyama Y,et al.Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors[J].Science,1998,279:577-580.
  • 4De matteo RP,Lewis JJ,Leung D.Two hundred gastrointestinal stromal tumors[J].Ann Surg,2000,231:51-58.
  • 5罗容珍,梁小曼,何洁华,侯景辉,饶慧兰.154例胃肠道间质瘤的临床病理及免疫组化特征[J].广东医学,2004,25(3):244-246. 被引量:18
  • 6Ando N,Goto H,Niwa Y,et al.The diagnosis of GI stromal tumors with EUS guided fine needle aspiration with immunohistochemical analysis[J].Gastrointest Endosc,2002,55:37-43.
  • 7XJ Wang,Ichiro Mori,WH Tang.Helpful parameter for malignant potential of gastrointestinal stromal tumors (GIST)[J].Japan J Clin Oncol,2002,32(9):347-351.
  • 8廖国庆,王志明.胃肠道间质瘤[J].中国普通外科杂志,1998,7(3):165-168. 被引量:19
  • 9VanOosterom AT,Judson I,Verweij J,et al.Safety and efficacy of imatinib (ST1571) in metastatic gastrointestinal stromal tumors:a phase I study[J].Lancet,2001,358 (9291):1412-1413.
  • 10Demetri GD,VonMehren M,Blanke CD,et al.Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors[J].N Eng J Med,2001,347 (7):472-476.

二级参考文献14

  • 1张艳仙,沈明.胃肠道间质性肿瘤的病理学研究[J].中国普通外科杂志,1995,4(1):10-15. 被引量:6
  • 2赵海潞,纪小龙.消化道间叶性肿瘤的新认识[J].新消化病学杂志,1996,4(2):100-101. 被引量:19
  • 3Miettinen M, Lasota J. Gastrointestinal stromal tumors - definition, clinical, histdogical, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch, 2001, 438:1.
  • 4Franquemont DW. Differentiation and risk assessment of gastrointestinal stromal tumors. Am J Clin Pathol, 1995,103:41.
  • 5Dematteo RP,Lewis JJ,Leung D,et al.Two hundred gastrointestinal stromal tumors.Ann Surg,2000,231:51
  • 6Emory TS, Sobin LL,Lukus L, et al. Prognosis of gastrointestinal smooth-muscle(stromal)tumors. Am J Surg Pathd, 1999, 23(1):82.
  • 7Reith JD, Goldblum JR, Lyles RH, et al.Extragastrointestinal(soft tissue)stromal tumors: an analysis of 48 cases with emphasis on histotogic predictors of outcome. Mod Pathol, 2000,13(5):577.
  • 8Tazawa K, Tsukada T, Makuuchi H, et al. An immunohistochemical and clincopathdogical study of gastrointestinal stromal tumors. Pathology international, 1999, 49: 786.
  • 9Miettinen M, Sobin LH, Sarlomo- Rikala M, et al.Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117(KIT).Mod Pathol,2000,13(10):1134
  • 10Saul Suster, Cyril Fisher, Cesar Moran.Expresion of bcl - 2 oncoprotein benign and malignant spindle cell tumors of salt tissue, skin, semsal surfaces, and gastrointestinal tract. Am J Surg Pathol, 1998, 22(7):863.

共引文献184

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部